Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice (2019)
- Authors:
- Furigo, Isadora Clivatti
- Suzuki, Miriam Fussae
- Oliveria, João Ezequiel de
- Lobo, Angela Maria Ramos
- Teixeira, Pryscila Dryelle Sousa
- Pedroso, João Alfredo Bolivar
- Alencar, Amanda de
- Zampieri, Thais Tessari
- Buonfiglio, Daniella do Carmo
- Bergonsi, Paula Gabriele Fernandes Quaresma
- Prada, Patrícia de Oliveira
- Bartolini, Paolo
- Soares, Carlos Roberto Jorge
- Donato Junior, José
- Furigo, Isadora Clivatti
- USP affiliated authors: DONATO JÚNIOR, JOSÉ - ICB ; FURIGO, ISADORA CLIVATTI - ICB ; LOBO, ANGELA MARIA RAMOS - ICB ; TEIXEIRA, PRYSCILA DRYELLE SOUSA - ICB ; PEDROSO, JOÃO ALFREDO BOLIVAR - ICB ; ZAMPIERI, THAIS TESSARI - ICB ; BUONFIGLIO, DANIELLA DO CARMO - ICB ; BERGONSI, PAULA GABRIELE FERNANDES QUARESMA - ICB
- Unidade: ICB
- DOI: 10.1210/en.2018-00629
- Subjects: FISIOLOGIA; PROLACTINA; OBESIDADE; DIABETES MELLITUS; RECEPTORES DE DOPAMINA; BROMO; INSULINA; GLICOSE; RESISTÊNCIA À INSULINA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Endocrinology
- ISSN: 1945-7170
- Volume/Número/Paginação/Ano: v. 160, n. 1, p. 193-204, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FURIGO, Isadora Clivatti et al. Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice. Endocrinology, v. 160, n. 1, p. 193-204, 2019Tradução . . Disponível em: https://doi.org/10.1210/en.2018-00629. Acesso em: 30 dez. 2025. -
APA
Furigo, I. C., Suzuki, M. F., Oliveria, J. E. de, Lobo, A. M. R., Teixeira, P. D. S., Pedroso, J. A. B., et al. (2019). Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice. Endocrinology, 160( 1), 193-204. doi:10.1210/en.2018-00629 -
NLM
Furigo IC, Suzuki MF, Oliveria JE de, Lobo AMR, Teixeira PDS, Pedroso JAB, Alencar A de, Zampieri TT, Buonfiglio D do C, Bergonsi PGFQ, Prada P de O, Bartolini P, Soares CRJ, Donato Junior J. Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice [Internet]. Endocrinology. 2019 ; 160( 1): 193-204.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1210/en.2018-00629 -
Vancouver
Furigo IC, Suzuki MF, Oliveria JE de, Lobo AMR, Teixeira PDS, Pedroso JAB, Alencar A de, Zampieri TT, Buonfiglio D do C, Bergonsi PGFQ, Prada P de O, Bartolini P, Soares CRJ, Donato Junior J. Suppression of prolactin secretion partially explains the antidiabetic effect of bromocriptine in ob/ob mice [Internet]. Endocrinology. 2019 ; 160( 1): 193-204.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1210/en.2018-00629 - Long-term consequences of the absence of leptin signaling in early life
- Brain STAT5 modulates long-term metabolic and epigenetic changes induced by pregnancy and lactation in female mice
- SOCS3 as a future target to treat metabolic disorders
- Growth hormone/STAT5 signaling in proopiomelanocortin neurons regulates glucoprivic hyperphagia
- Growth hormone receptor deletion reduces the density of axonal projections from hypothalamic arcuate nucleus neurons
- Central growth hormone action regulates metabolism during pregnancy
- Removing melatonin receptor type 1 signaling leads to selective leptin resistance in the arcuate nucleus
- Deletion of growth hormone receptor in hypothalamic neurons affects the adaptation capacity to aerobic exercise
- Leptin receptor reactivation restores brain function in early-life Lepr-deficient mice
- Maternal obesity increases hypothalamic miR-505-5p expression in mouse offspring leading to altered fatty acid sensing and increased intake of high-fat food
Informações sobre o DOI: 10.1210/en.2018-00629 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Suppression_of_Prolactin_... |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
